These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 23774210)
1. Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases. Chantôme A; Potier-Cartereau M; Clarysse L; Fromont G; Marionneau-Lambot S; Guéguinou M; Pagès JC; Collin C; Oullier T; Girault A; Arbion F; Haelters JP; Jaffrès PA; Pinault M; Besson P; Joulin V; Bougnoux P; Vandier C Cancer Res; 2013 Aug; 73(15):4852-61. PubMed ID: 23774210 [TBL] [Abstract][Full Text] [Related]
2. cAMP-PKA inhibition of SK3 channel reduced both Ca2+ entry and cancer cell migration by regulation of SK3-Orai1 complex. Clarysse L; Guéguinou M; Potier-Cartereau M; Vandecasteele G; Bougnoux P; Chevalier S; Chantôme A; Vandier C Pflugers Arch; 2014 Oct; 466(10):1921-32. PubMed ID: 24458591 [TBL] [Abstract][Full Text] [Related]
3. SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline. Guéguinou M; Harnois T; Crottes D; Uguen A; Deliot N; Gambade A; Chantôme A; Haelters JP; Jaffrès PA; Jourdan ML; Weber G; Soriani O; Bougnoux P; Mignen O; Bourmeyster N; Constantin B; Lecomte T; Vandier C; Potier-Cartereau M Oncotarget; 2016 Jun; 7(24):36168-36184. PubMed ID: 27102434 [TBL] [Abstract][Full Text] [Related]
4. The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca Gueguinou M; Crottès D; Chantôme A; Rapetti-Mauss R; Potier-Cartereau M; Clarysse L; Girault A; Fourbon Y; Jézéquel P; Guérin-Charbonnel C; Fromont G; Martin P; Pellissier B; Schiappa R; Chamorey E; Mignen O; Uguen A; Borgese F; Vandier C; Soriani O Oncogene; 2017 Jun; 36(25):3640-3647. PubMed ID: 28114279 [TBL] [Abstract][Full Text] [Related]
5. Orai1 forms a signal complex with SK3 channel in gallbladder smooth muscle. Song K; Zhong XG; Xia XM; Huang JH; Fan YF; Yuan RX; Xue NR; Du J; Han WX; Xu AM; Shen B Biochem Biophys Res Commun; 2015 Oct; 466(3):456-62. PubMed ID: 26367175 [TBL] [Abstract][Full Text] [Related]
6. New Disaccharide-Based Ether Lipids as SK3 Ion Channel Inhibitors. Berthe W; Sevrain CM; Chantôme A; Bouchet AM; Gueguinou M; Fourbon Y; Potier-Cartereau M; Haelters JP; Couthon-Gourvès H; Vandier C; Jaffrès PA ChemMedChem; 2016 Jul; 11(14):1531-9. PubMed ID: 27278812 [TBL] [Abstract][Full Text] [Related]
7. New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis. Girault A; Haelters JP; Potier-Cartereau M; Chantome A; Pinault M; Marionneau-Lambot S; Oullier T; Simon G; Couthon-Gourvès H; Jaffrès PA; Corbel B; Bougnoux P; Joulin V; Vandier C Curr Cancer Drug Targets; 2011 Nov; 11(9):1111-25. PubMed ID: 21999627 [TBL] [Abstract][Full Text] [Related]
8. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. Hammadi M; Chopin V; Matifat F; Dhennin-Duthille I; Chasseraud M; Sevestre H; Ouadid-Ahidouch H J Cell Physiol; 2012 Dec; 227(12):3837-46. PubMed ID: 22495877 [TBL] [Abstract][Full Text] [Related]
9. The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine. Potier M; Chantome A; Joulin V; Girault A; Roger S; Besson P; Jourdan ML; LeGuennec JY; Bougnoux P; Vandier C Br J Pharmacol; 2011 Jan; 162(2):464-79. PubMed ID: 20955368 [TBL] [Abstract][Full Text] [Related]
10. Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity. Kouba S; Braire J; Félix R; Chantôme A; Jaffrès PA; Lebreton J; Dubreuil D; Pipelier M; Zhang X; Trebak M; Vandier C; Mathé-Allainmat M; Potier-Cartereau M Eur J Med Chem; 2020 Jan; 186():111854. PubMed ID: 31753515 [TBL] [Abstract][Full Text] [Related]
11. Small-conductance, calcium-activated potassium channel 3 (SK3) is a modulator of endometrial remodeling during endometrial growth. Lu YC; Yang J; Ding GL; Shi S; Zhang D; Jin L; Pan JX; Lin XH; Zhu YM; Sheng JZ; Huang HF J Clin Endocrinol Metab; 2014 Oct; 99(10):3800-10. PubMed ID: 24978672 [TBL] [Abstract][Full Text] [Related]
12. Identification of SK3 channel as a new mediator of breast cancer cell migration. Potier M; Joulin V; Roger S; Besson P; Jourdan ML; Leguennec JY; Bougnoux P; Vandier C Mol Cancer Ther; 2006 Nov; 5(11):2946-53. PubMed ID: 17121942 [TBL] [Abstract][Full Text] [Related]
13. Endogenous ether lipids differentially promote tumor aggressiveness by regulating the SK3 channel. Papin M; Fontaine D; Goupille C; Figiel S; Domingo I; Pinault M; Guimaraes C; Guyon N; Cartron PF; Emond P; Lefevre A; Gueguinou M; Crottès D; Jaffrès PA; Ouldamer L; Maheo K; Fromont G; Potier-Cartereau M; Bougnoux P; Chantôme A; Vandier C J Lipid Res; 2024 May; 65(5):100544. PubMed ID: 38642894 [TBL] [Abstract][Full Text] [Related]
14. The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells. Steinestel K; Eder S; Ehinger K; Schneider J; Genze F; Winkler E; Wardelmann E; Schrader AJ; Steinestel J Tumour Biol; 2016 May; 37(5):6275-83. PubMed ID: 26619845 [TBL] [Abstract][Full Text] [Related]
15. DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor. Sevrain CM; Haelters JP; Chantôme A; Couthon-Gourvès H; Gueguinou M; Potier-Cartereau M; Vandier C; Jaffrès PA Org Biomol Chem; 2013 Jul; 11(27):4479-87. PubMed ID: 23715410 [TBL] [Abstract][Full Text] [Related]
16. Development of pyrene-based fluorescent ether lipid as inhibitor of SK3 ion channels. Bauduin A; Papin M; Chantôme A; Couthon H; Deschamps L; Requejo-Isidro J; Vandier C; Jaffrès PA Eur J Med Chem; 2021 Jan; 209():112894. PubMed ID: 33049604 [TBL] [Abstract][Full Text] [Related]
18. Small-conductance calcium-activated K(+) channels 3 (SK3) regulate blastocyst hatching by control of intracellular calcium concentration. Lu YC; Ding GL; Yang J; Zhang YL; Shi S; Zhang RJ; Zhang D; Pan JX; Sheng JZ; Huang HF Hum Reprod; 2012 May; 27(5):1421-30. PubMed ID: 22416006 [TBL] [Abstract][Full Text] [Related]
19. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Yang S; Zhang JJ; Huang XY Cancer Cell; 2009 Feb; 15(2):124-34. PubMed ID: 19185847 [TBL] [Abstract][Full Text] [Related]
20. Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry. Stanisz H; Saul S; Müller CS; Kappl R; Niemeyer BA; Vogt T; Hoth M; Roesch A; Bogeski I Pigment Cell Melanoma Res; 2014 May; 27(3):442-53. PubMed ID: 24472175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]